Abstract
DNA aptamers (oligonucleotides) interacting with thrombin exosite I contain G-quadruplex, two T-T, and one T-G-T loops in their structure. They prevent exosite I binding with fibrinogen and thrombin receptors on platelet surface, thereby suppressing thrombin-stimulated formation of fibrin from fibrinogen and platelet aggregation. Earlier, we synthe-sized original antithrombin aptamer RE31 (5′-GTGACGTAGGTTGGTGTGGTTGGGGCGTCAC-3′) that contained (in addition to G-quadruplex) a hinge region connected to six pairs of complementary bases (duplex region). In this study, we compared properties of RE31 aptamer and its analogues containing varying number of bases in the duplex region and nucleotide insertions in the hinge region. Reduction in the number of nucleotides in the duplex region by 1 to 4 pairs (in comparison with RE31 aptamer) resulted in the decrease of the structural stability of aptamers (manifested as lower melting temperatures) and their ability to inhibit thrombin-stimulated fibrin formation in human blood plasma in tests of thrombin, prothrombin, and activated partial thromboplastin times. However, an increase in the number of bases by 1 to 2 pairs did not cause significant changes in the stability and antithrombin activity of the aptamers. Insertions into the hinge region of RE31 aptamer decreased its antithrombin activity. Investigation of RE31 antithrombotic properties demonstrated that RE31 (i) slowed down thrombin formation in human blood plasma (thrombin generation test), (ii) accelerated lysis of fibrin clot by tissue plasminogen activator in in vitro model, and (iii) suppressed arterial thrombosis in in vivo model. Based on the obtained data, RE31 aptamer can be considered as a potentially effective antithrombotic compound.
Similar content being viewed by others
Abbreviations
- APTT:
-
activated partial thromboplastin time
- PCI:
-
potato carboxypeptidase inhibitor
- TAFI:
-
thrombin-activated fibrinolysis inhibitor
- TBA:
-
thrombin-binding aptamer
- tPA:
-
tissue plasminogen activator
References
Keefe, A. D., Pai, S., and Ellington, A. (2010) Aptamers as therapeutics, Nat. Rev. Drug Discov., 9, 537–550. doi: 10.1038/nrd3141.
Ni, X., Castanres, M., Mukherjee, A., and Lupoid, S. E. (2011) Nucleic acid aptamers: clinical application and promising new horizons, Curr. Med. Chem., 18, 4206–4214.
Li, W., Wang, K., Zhao, M., Yang, X., Chen, M., and Lan, X. (2014) Development of aptamer oligonucleotides as anticoagulants and antithrombotics for cardiovascular diseases: current status, Thromb. Res., 134, 769–773. doi: 10.1016/j.thromres.2014.05.021.
Crawley, J. T., Zanardelli, S., Chion, C. K., and Lane, D. A. (2007) The central role of thrombin in hemostasis, J. Thromb. Haemost., 5, 95–101. doi: 10.1111/j.1538-7836.2007.02500.x.
Bock, L. C., Griffin, L. C., Latham, J. A., Vermaas, E. H., and Toole, J. J. (1992) Selection of single-stranded DNA molecules that bind and inhibit human thrombin, Nature.355, 564–566. doi: 10.1038/355564a0.
Macaya, R. F., Schultze, P., Smith, F. W., Roe, J. A., and Feigon, J. (1993) Thrombin-binding DNA aptamer forms a unimolecular quadruplex structure in solution, Proc. Natl. Acad. Sci. USA.90, 3745–3749. doi: 10.1073/pnas.90.8.3745.
Padmanabhan, K. P., Ferrara, J. D., Sadker, J. E., and Tulinsky, A. (1993) The structure of α-thrombin inhibited by a 15-mer single-stranded DNA aptamer, J. Biol. Chem., 268, 17651–17654. doi: 10.2210/pdb1hut/pdb.
Russo Krauss, I. R., Spiridonova, V., Pica, A., Napolitano, V., and Sica, F. (2016) Different duplex/quadruplex junctions determine the properties of antithrombin aptamers with mixed folding, Nucleic Acids Res., 44, 983–991. doi: 10.1093/nar/gkv1384.
Dobrovolsky, A. B., Titaeva, E. V., Khaspekova, S. G., Spiridonova, V. A., Kopylov, A. M., and Mazurov, A. V. (2009) Inhibition of thrombin activity with DNA aptamers, Bull. Exp. Biol. Med., 148, 33; doi: 10.1007/s10517-009-0627-7.
Spiridonova, V. A., Golovin, A. V., Kopylov, A. M., Dobrovolsky, A. B., and Mazurov, A. V. (2010) Aptameric oligonucleotide–direct inhibitor of thrombin, RF Patent 2401306, Byull. Izobret., no. 28.
Russo Krauss, I., Napolitano, V., Petraccone, L., Troisi, R., Spiridonova, V., Mattia, C. A., and Sica, F. (2018) Duplex/quadruplex oligonucleotides: role of the duplex domain in the stabilization of a new generation of highly effective antithrombin aptamers, Int. J. Biol. Macromol., 107 (Pt. B), 1697–1705; doi: 10.1016/j.ijbiomac.2017.10.033.
Mazurov, A. V., Titaeva, E. V., Khaspekova, S. G., Storozhilova, A. N., Spiridonova, V. A., Kopylov, A. M., and Dobrovolsky, A. B. (2011) Characteristics of a new aptamer, direct inhibitor of thrombin, Bull. Exp. Biol. Med., 150, 422–425. doi: 10.1007/s10517-011-1158-6.
Spiridonova, V. A., Golovin, A. V., Kopylov, A. M., Dobrovolsky, A. B., and Mazurov, A. V. (2011) Modified DNA aptamers that inhibit thrombin activity, RF Patent 2410432, Byull. Izobret., no. 3.
Nagatoishi, S., Tanaka, Y., and Tsumoto, K. (2007) Circular dichroism spectra demonstrate formation of the thrombin-binding DNA aptamer G-quadruplex under stabilizingcation-deficient conditions, Biochem. Biophys. Res. Commun., 352, 812–817. doi: 10.1016/j.bbrc.2006.11.088.
Dolinnaya, N. G., Ogloblina, A M., and Yakubovskaya, M. G. (2016) Structure, properties, and biological relevance of the DNA and RNA G-quadruplexes: overview 50 years after their discovery, Biochemistry (Moscow).81, 1602–1649; doi: 10.1134/S0006297916130034.
Mutch, N. J., Thomas, L., Moore, N. R., Lisiak, K. M., and Booth, N. A. (2007) TAFIa, PAI-1 and a2-antiplasmin: complementary roles in regulating lysis of thrombi and plasma clots, J. Thromb. Haemost., 5, 812–817. doi: 10.1111/j.1538-7836.2007.02430.x.
Kurz, K. D., Main, B. W., and Sandunsky, G. E. (1990) Rat model of arterial thrombosis by ferric chloride, Thromb. Res., 15, 269–280.
Maksimenko, A. V., Golubykh, V. L., and Tischenko, E. G. (2003) Catalase and chondroitin sulfate derivatives against thrombotic effect induced by reactive oxygen species in a rat artery, Metab. Eng., 5, 177–182.
Bouma, B. N., and Meijers, J. C. M. (2003) Thrombin-activatable fibrinolysis inhibitor (TAFI, plasma procar-boxypeptidase B, procarboxypeptidase R, procarboxypeptidase U), J. Thromb. Haemost., 1, 1566–1574.
Spiridonova, V. A., Barinova, K. V., Glinkina, K. A., Melnichuk, A. V., Gainutdynov, A. A., Safenkova, I. V., and Dzantiev, B. B. (2015) A family of DNA aptamers with varied duplex region length that forms complexes with thrombin and prothrombin, FEBS Lett., 589, 2043–2049. doi: 10.1016/j.febslet.2015.06.020.
Kretz, C. A., Cuddy, K. K., Stafford, A. R., Fredenburgh, J. C., Roberts, R., and Weitz, J. I. (2010) HD1, a thrombin- and prothrombin-binding DNA aptamer, inhibits thrombin generation by attenuating prothrombin activation and thrombin feedback reactions, Thromb. Haemost., 103, 83–93; doi: 10.1160/TH09-04-0237.
Kretz, C. A., Stafford, A. R., Fredenburgh, J. C., and Weitz, J. I. (2006) HD1, a thrombin-directed aptamer, binds exosite 1 on prothrombin with high affinity and inhibits its activation by prothrombinase, J. Biol. Chem., 281, 37477–37485. doi: 10.1074/jbc.M607359200.
Bukys, M. A., Orban, T., Kim, P. Y., Beck, D. O., Nesheim, M. E., and Kalafatis, M. (2006) The structural integrity of anion binding exosite I of thrombin is required and sufficient for timely cleavage and activation of factor V and factor VIII, J. Biol. Chem., 281, 18569–18580. doi: 10.1074/jbc.M600752200.
Petrera, N. S., Stafford, A. R., Leslie, B. A., Kretz, C. A., Fredenburgh, J. C., and Weitz, J. I. (2009) Long range communication between exosites 1 and 2 modulates thrombin function, J. Biol. Chem., 284, 25620–25629. doi: 10.1074/jbc.M109.000042.
Tan, X., Dey, S. K., Telmer, C., Zhang, X., Armitage, B. A., and Bruchez, M. P. (2014) Aptamers act as activators for the thrombin mediated-hydrolysis of peptide substrates, ChemBioChem.15, 205–208. doi: 10.1002/cbic.201300693.
Author information
Authors and Affiliations
Corresponding author
Additional information
Conflict of interest. The authors declare no conflict of interest in financial or any other sphere.
Ethical approval. This article does not contain any studies with human participants. All applicable international, national, and/or institutional guidelines for the care and use of animals were followed.
Russian Text © The Author(s), 2019, published in Biokhimiya, 2019, Vol. 84, No. 12, pp. 1876–1885.
Rights and permissions
About this article
Cite this article
Spiridonova, V.A., Novikova, T.M., Sizov, V.A. et al. DNA Aptamers to Thrombin Exosite I. Structure-Function Relationships and Antithrombotic Effects. Biochemistry Moscow 84, 1521–1528 (2019). https://doi.org/10.1134/S0006297919120113
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1134/S0006297919120113